IP Library Granted Patent US 11,179,305
Granted Patent B2
US 11,179,305 · App. 16/898,120 · Granted Nov 23, 2021

Topical compositions

Inventors: Tiffany Carle (Dallas, TX); Michael Frushour (Addison, TX); David Gan (Southlake, TX); Geetha Kalahasti (Plano, TX); Patricia Jacoby (Dallas, TX)
Assignee: MARY KAY INC.
A61K8/347A61K8/11A61K8/606A61K8/64A61K8/675A61K8/97A61K8/9706A61K8/9711A61K8/9789A61Q17/04A61Q19/02A61Q19/08A61Q19/10A61K2800/782
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,179,305
App. No.
16/898,120
Granted
Nov 23, 2021
Kind
B2
Abstract

A method of reducing oxidative damage of skin is described. The method can include applying to oxidant damaged skin a topical composition that includes encapsulated resveratrol, oligopeptide-1, and niacinamide, wherein the combination of encapsulated resveratrol, oligopeptide-1, and niacinamide reduces oxidative damage in the skin, and wherein the oligopeptide-1 comprises the sequence of caprooyl-Gly-His-Lys-Lys.

Claims (16)

1. A method of reducing oxidative damage of skin comprising applying to oxidant damaged skin a topical composition comprising encapsulated resveratrol, oligopeptide-1, and niacinamide, wherein the combination of encapsulated resveratrol, oligopeptide-1, and niacinamide reduces oxidative damage in the skin, and wherein the oligopeptide-1 comprises the sequence of caprooyl-Gly-His-Lys-Lys.

2. The method of claim 1 , wherein the oligopeptide-1 inhibits tyrosinase, increases production of elastin, stimulates collagen production and/or secretion, and/or inhibits TNF-α; and niacinamide inhibits melanogenesis.

3. The method of claim 1 , wherein the topical composition is applied to the skin daily.

4. The method of claim 1 , wherein the topical composition comprises 0.00001 to 0.1% by weight of encapsulated resveratrol, 0.0000001 to 0.01% by weight of oligopeptide-1, and 0.001 to 3% by weight of niacinamide.

5. The method of claim 4 , wherein the topical composition is formulated as a sunscreen and further comprises 5 to 15% by weight of homosalate, 1 to 10% by weight each of ethylhexyl salicylate and oxybenzone, 0.1 to 10% by weight each of butyl methoxydibenzoylmethane and octocrylene, 0.1 to 5% by weight each of dicapryl carbonate, dimethicone, ammonium acryloyldimethyltaurate/VP copolymer, cetearyl alcohol, and ceteareth-25, 0.01 to 3% by weight each of disodium ethylene dicocamide PEG-15 disulfate, silica, and caprylyl glycol, and 0.01 to 1% by weight each of bisabolol, and tocopheryl acetate.

6. The method of claim 4 , wherein the topical composition is formulated as a day moisturizer and further comprises 10 to 15% by weight of isopropyl palmitate and 0.1 to 10% by weight each of glyceryl stearate, PEG-100 stearate, butylene glycol, glycerine, methyl trimethicone, silica, mica, ammonium acryloyldimethyltaurate/VP copolymer, lauryl PEG-9 polydimethylsiloxyethyl dimethicone, isostearyl neopentanoate, cetyl phosphate, and triethanolamine.

7. The method of claim 4 , wherein the composition is formulated as a night moisturizer and further comprises 0.01 to 15% by weight of dimethicone, 0.01 to 10% by weight of isohexadecane, 0.1 to 10% by weight of aluminum starch octenylsuccinate, and 0.01 to 5% by weight each of caprylic/capric triglyceride, cetearyl alcohol, glyceryl stearate, butylene glycol, and hydroxyacetophenone.

8. The method of claim 4 , wherein the topical composition is formulated as a cleanser and comprises 0.1 to 10% by weight each of acrylates copolymer, cocoamidopropyl betaine, propanediol, and PPG-2-hydroxyethyl coco/isostearamide, and 0.01 to 1% by weight each of Copernicia cerifera (Carnauba) wax, sodium chloride, and lactose.

9. The method of claim 4 , wherein the topical composition is formulated as a foundation and further comprises 20 to 40% by weight of cyclopentasiloxane and 1 to 15% by weight each of titanium dioxide, butylene glycol, PEG-9 dimethicone, trimethylsiloxysilicate, lauryl methacrylate/glycol dimethacrylate crosspolymer, PEG/PPG-20/15 dimethicone, magnesium sulfate, and polymethylsilsesquioxane.

10. The method of claim 1 , wherein the composition is an emulsion.

11. The method of claim 1 , wherein the emulsion is an oil-in-water emulsion.

12. The method of claim 1 , wherein the composition is a cream or lotion.

13. The method of claim 1 , wherein the composition is a gel.

14. The method of claim 1 , wherein the composition is a solution.

15. The method of claim 1 , wherein the composition comprises 25 to 98% by weight of water.

16. The method of claim 1 , wherein the composition is applied to a fine line or wrinkle.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 26, 2024
From: MARY KAY INC.
To: ALLUSTRA TECHNOLOGIES LLC
Reel/Frame 069414/0659 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2020
From: CARLE, TIFFANY; FRUSHOUR, MICHAEL; GAN, DAVID; KALAHASTI, GEETHA; JACOBY, PATRICIA
To: MARY KAY INC.
Reel/Frame 052899/0651 →
Continuity (3)
Continuation 15233451 · Aug 10, 2016
Provisional Application 62203155 · Aug 10, 2015
Related Publication 20200297600A1 · Sep 24, 2020